Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 11, 2023

BUY
$4.89 - $10.57 $51,980 - $112,359
10,630 Added 7.09%
160,630 $1.6 Million
Q1 2023

May 15, 2023

BUY
$5.62 - $11.51 $843,000 - $1.73 Million
150,000 New
150,000 $870,000

Others Institutions Holding ICVX

About Icosavax, Inc.


  • Ticker ICVX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,885,200
  • Description
  • Icosavax, Inc., a biopharmaceutical company, develops vaccines against infectious diseases. The company, with the help of its virus-like particle (VLP) platform technology, focuses primarily on life-threatening respiratory diseases. Its products in pipeline include IVX-121, a vaccine candidate with RSV target and is under Phase 1/1b clinical tri...
More about ICVX
Track This Portfolio

Track Velan Capital Investment Management LP Portfolio

Follow Velan Capital Investment Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Velan Capital Investment Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Velan Capital Investment Management LP with notifications on news.